What question did this study set out to answer?

To review recent updates in the diagnostic criteria, pathophysiologic mechanisms, and clinical management strategies for hepatorenal syndrome-acute kidney injury in cirrhotic patients.

July 17, 2026Current Opinion in Nephrology & Hypertension

Advances in the management of Hepatorenal syndrome

View Full Paper

Ask AI

Bookmark

Authors

DJDinesh Jothimani SKSarah Khan SDSravanthi Devireddy

Discussion

Member takes

Overview

Review highlights evolving diagnostic criteria and targeted therapies in hepatorenal syndrome, emphasizing liver transplantation as the definitive curative intervention.

Key Points

To review recent updates in the diagnostic criteria, pathophysiologic mechanisms, and clinical management strategies for hepatorenal syndrome-acute kidney injury in cirrhotic patients.
Synthesized current clinical evidence and updated diagnostic criteria for hepatorenal syndrome-acute kidney injury (HRS-AKI).
Evaluated pharmacologic and interventional management protocols, including volume expansion, vasoconstrictor therapy, and liver transplantation across decompensated cirrhosis and acute-on-chronic liver failure.
Intravascular volume expansion paired with vasoconstrictor therapy serves as the primary medical intervention, with therapeutic success dictated by the timing of initiation, dosing, and physiological monitoring.
Medical therapy alone yields high disease recurrence and poor overall survival, confirming that liver transplantation remains the sole definitive cure for HRS-AKI.

Cite This Study

Jothimani et al. (2026) studied this question.

synapsesocial.com/papers/6a7cb472f40403d04c3f7198 https://doi.org/10.1097/mnh.0000000000001212

View Full Paper

Ask AI

Bookmark

July 17, 2026Current Opinion in Nephrology & Hypertension

Advances in the management of Hepatorenal syndrome

View Full Paper

Ask AI

Bookmark

Authors

DJDinesh Jothimani SKSarah Khan SDSravanthi Devireddy

Discussion

Member takes

Overview

Review highlights evolving diagnostic criteria and targeted therapies in hepatorenal syndrome, emphasizing liver transplantation as the definitive curative intervention.

Key Points

To review recent updates in the diagnostic criteria, pathophysiologic mechanisms, and clinical management strategies for hepatorenal syndrome-acute kidney injury in cirrhotic patients.
Synthesized current clinical evidence and updated diagnostic criteria for hepatorenal syndrome-acute kidney injury (HRS-AKI).
Evaluated pharmacologic and interventional management protocols, including volume expansion, vasoconstrictor therapy, and liver transplantation across decompensated cirrhosis and acute-on-chronic liver failure.
Intravascular volume expansion paired with vasoconstrictor therapy serves as the primary medical intervention, with therapeutic success dictated by the timing of initiation, dosing, and physiological monitoring.
Medical therapy alone yields high disease recurrence and poor overall survival, confirming that liver transplantation remains the sole definitive cure for HRS-AKI.

Cite This Study

Jothimani et al. (2026) studied this question.

synapsesocial.com/papers/6a7cb472f40403d04c3f7198 https://doi.org/10.1097/mnh.0000000000001212

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark